Heart Failure 2018 & World Congress on Acute Heart Failure

26 - 29 May 2018, Vienna - Austria

Session Details

Patient management - From oral treatment to transplant
Mon 28 May 14:15 - 15:45 Chronic Heart Failure Rapid Fire Abstract Agora -
Chairpersons: Alan FRASER (Cardiff, United Kingdom), Christian HENGSTENBERG (Wien, Austria)
Learning Objectives: Rapid fire abstracts sessions are dynamic and interactive presentations of related topic abstracts. Presentation slides and ePoster will be available for further consultation on the Scientific Programme & Planner

Access slides, videos, reports online via ESC Congress 365 Other resources

List of Presentations

Time
 
FP Nr
 
Title
 
Speakers
 
Related documents
14:151536Structured follow-up program of patients with heart failure: impact on quality of life and prognosis.Joao Pedro Ribeiro AGOSTINHO (Lisboa, Portugal)
14:211537Impact of physicians' adherence to guideline-recommended therapy on heart failure re-hospitalizations: data from the Optimize Heart Failure Care ProgramAnna GREBENNIKOVA (Volgograd, Russian Federation)
14:271538Perceptions of heart failure treatment decision-making and side effects of heart failure treatment by patients and cardiologists: a multinational survey in the real-world cardiology settingSara BRUCE WIRTA (Basel, Switzerland)
14:331539CANCELLED - The effect of home-based cardiac rehabilitation following coronary artery bypass graft surgery in a low income country: A controlled trialJamal UDDIN (Dhaka, Bangladesh)
14:391540The optimal plasma volume status in heart failure in relation to clinical outcomePieter MARTENS (Genk, Belgium)
14:451541Empagliflozin improves renal outcomes in patients with or without heart failure at baseline - insights from the EMPA-REG OUTCOME trialJaved BUTLER (Atlanta, United States of America)
14:511542The ketone body 3-hydroxybutyrate increases cardiac output and left ventricular contractile function in heart failure patients with reduced ejection fractionRoni NIELSEN (Aarhus N, Denmark)
14:571543Are target doses relevant for women with heart failure? - implications for sacubitril-valsartanHelena NORBERG (Umea, Sweden)
15:031544Real-world titration and treatment patterns of sacubitril/valsartan in germany, a retrospective cohort study using a longitudinal pharmacy databaseRolf WACHTER (Leipzig, Germany)
15:091545Persistence and compliance amongst sacubitril/valsartan patients in germany, a retrospective cohort study from a longitudinal pharmacy databaseSara BRUCE WIRTA (Basel, Switzerland)
15:151546Impact of patisiran on norfolk QOL-DN in patients with hereditary transthyretin-mediated amyloidosis: results from the cardiac subpopulation in the phase 3 apollo studyVerena KARSTEN (Cambridge, United States of America)
15:211547Concomitant use of heart failure medication amongst patients with sacubitril/valsartan therapy in germany, a retrospective cohort study using a longitudinal pharmacy databaseRolf WACHTER (Leipzig, Germany)
15:271548CANCELLED - Noninvasive recognition of experimental cardiac allograft rejection by molecular targeting of apoptotic process with radiolabeled duramycin in vivo 
15:331549The association between implantable defibrillators and all-cause mortality in left ventricular assist device carriers - initial results of a propensity score adjusted analysisMaja CIKES (Zagreb, Croatia)
15:391550CANCELLED - Are there differences in the outcomes of ischemic and non-ischemic cardiomyopathy in the current era?Raed ODEH (Riyadh, Saudi Arabia)